MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

Search

ResMed Inc

Slēgts

SektorsVeselības aprūpe

222.77 0.32

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

218.13

Max

223.3

Galvenie mērījumi

By Trading Economics

Ienākumi

33M

345M

Pārdošana

62M

1.3B

P/E

Sektora vidējais

26.46

63.778

EPS

2.43

Dividenžu ienesīgums

0.95

Peļņas marža

26.88

EBITDA

-79M

362M

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt

Prognoze 12 mēnešiem

+22.02% upside

Dividendes

By Dow Jones

Dividenžu ienesīgums

Sektora vidējais

0.95%

2.39%

Nākamie ieņēmumi

2025. g. 24. apr.

Nākamais dividenžu datums

2025. g. 12. jūn.

Nākamais Ex dividenžu datums

2025. g. 7. maijs

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

-1.9B

33B

Iepriekšējā atvēršanas cena

222.45

Iepriekšējā slēgšanas cena

222.77

Ziņu noskaņojums

By Acuity

49%

51%

178 / 386 Rangs Healthcare

ResMed Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2024. g. 24. jūn. 17:43 UTC

Galvenie tirgus virzītāji

Shares of ResMed, Inspire Medical Down After Eli Lilly Provides Sleep Apnea Study Update

2024. g. 7. nov. 03:53 UTC

Tirgus saruna

U.S. Tariffs Could Force Moves by Australian Med-Techs -- Market Talk

2024. g. 25. okt. 09:10 UTC

Peļņas

These Stocks Are Moving the Most Today: Tesla, Capri, Western Digital, Spirit Airlines, Deckers, Coursera, and More -- Barrons.com

2024. g. 25. okt. 08:35 UTC

Peļņas

These Stocks Are Moving the Most Today: Tesla, Capri, Western Digital, Spirit Airlines, Deckers, Coursera, and More -- Barrons.com

2024. g. 27. jūn. 16:01 UTC

Peļņas

ResMed Stock Is Down Because of GLP-1 Concerns. It Shouldn't Be. -- Barrons.com

2024. g. 24. jūn. 17:28 UTC

Galvenie tirgus virzītāji

ResMed, Inspire Medical Shares Down After Eli Lilly Provides Sleep Apnea Study Update

2024. g. 26. apr. 20:12 UTC

Peļņas

These Stocks Moved the Most Today: Alphabet, Microsoft, Intel, Snap, Exxon, Roku, Skechers, ResMed, and More -- Barrons.com

2024. g. 26. apr. 20:09 UTC

Peļņas

How 'Megatrends' Like Weight-Loss Drugs And Smartwatches Are Bolstering ResMed -- IBD

2024. g. 26. apr. 14:01 UTC

Peļņas

ResMed Soars To Eight-Month High As Quarterly Report Wipes Out Weight-Loss Woes -- IBD

Salīdzinājums

Cenas izmaiņa

ResMed Inc Prognoze

Cenas mērķis

By TipRanks

22.02% augšup

Prognoze 12 mēnešiem

Vidējais 272.11 USD  22.02%

Augstākais 290 USD

Zemākais 240 USD

Pamatojoties uz 13 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi ResMed Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt

13 ratings

8

Pirkt

5

Turēt

0

Pārdot

Noskaņojums

By Acuity

178 / 386 Rangs Veselības aprūpe

Ziņu noskaņojums

Liecība "Buļļu" tendencei

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Zem vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par ResMed Inc

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.